Checked.be
Active
BE 1011.997.238Public limited company
axabio
Nieuwe dreef 2 ·2620 Hemiksem, Belgium· 2 yrs active
Sector: Research and development on biotechnology
(72101)
Conclusion
axabio has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-653k) and a net result of €-2.37M. Its solvency ranks better than 8% of 84 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.1% (low).
Based on the State Gazette, CBE and 2 annual accounts.
Key figures
| Equity | €-653k |
| Net result | €-2.37M |
| Staff (FTE) | 11.1 |
| Better than sector | 8% |
Financial profile
53
/ 100
Mixed profile: strong on stability, weaker on health.
All 5 axes are computed from data Checked has read.
Health
27
Profitability
33
Solvency
67
Growth
55
Stability
82
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
Young company
Founded in 2024, under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
27
/ 100
Weak
Computed from 6 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 19-06-2026 with the NBB · fiscal year 2025 · full schema
Sector comparison
Fiscal year 2025 · NACE 72, Scientific research and development · compared across all schema types (micro, abbreviated and full combined)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -16.4% | 46.6% | |
| Net result | €-2.37M | €15k | |
| Equity | €-653k | €86k | |
| Total assets | €3.98M | €251k |
€384k
+762.4%
24-25
€-1.61M
-3.9%
24-25
€-2.37M
-2.6%
24-25
€-1.50M
+5.6%
24-25
€3.98M
+24.6%
24-25
€-653k
-
24-25
€560k
-
24-25
11
+6.7%
24-25
€1.14M
+78.7%
24-25
€4.63M
+93.7%
24-25
€463k
+42.3%
24-25
€4.17M
+101.8%
24-25
2.21
+182.3%
24-25
1.75
+154.4%
24-25
-16.4%
-
24-25
-7.10
-
24-25
363.2%
-
24-25
-59.6%
+17.7%
24-25
-616.7%
+88.1%
24-25
-418.4%
+88.0%
24-25
-13.88
+67.0%
24-25
Figures by fiscal year and ratios
| Fiscal year | 2025 |
|---|---|
| Deposit | full schema |
| Revenue | €384k |
| EBITDA | €-1.61M |
| Net profit | €-2.37M |
| Cash flow | €-1.50M |
| Staff costs | €1.14M |
| Income taxes | - |
| Dividends | - |
| Total assets | €3.98M |
| Equity | €-653k |
| Debt | €4.63M |
| of which ≤ 1y | €463k |
| of which > 1y | €4.17M |
| Working capital | €560k |
| Employees (FTE) | 11.1 |
Ratios (computed)
| 2025 | |
|---|---|
| Current ratio | 2.21 |
| Quick ratio | 1.75 |
| Working capital ratio | 14.1% |
| Solvency | -16.4% |
| Debt / equity | -7.10 |
| Long-term debt ratio | -6.39 |
| Interest coverage | -13.88 |
| Gross margin | -38.0% |
| Net margin | -616.7% |
| ROA | -59.6% |
| ROE | 363.2% |
| EBITDA margin | -418.4% |
| Days sales outstanding | 197d |
| Days payable outstanding | 242d |
| Inventory turnover | 2.47 |
| Days inventory (DSI) | 148d |
This table shows the latest fiscal year. 1 prior year, with figures and ratios, belongs to a paid plan.
See plans →
Balance-sheet composition 2025
Full annual accounts (24 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €3.98M |
| Fixed assets | 21/28 | €2.96M |
| Intangible fixed assets | 21 | €738k |
| Tangible fixed assets | 22/27 | €2.22M |
| Current assets | 29/58 | €1.02M |
| Stocks & contracts in progress | 3 | €215k |
| Amounts receivable within one year | 40/41 | €790k |
| Cash & bank | 54/58 | €1k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €3.98M |
| Equity | 10/15 | €-653k |
| Contributions / capital | 10/11 | €3.07M |
| Reserves | 13 | €44k |
| Accumulated profits (losses) | 14 | €-4.68M |
| Amounts payable | 17/49 | €4.63M |
| Amounts payable after one year | 17 | €4.17M |
| Amounts payable within one year | 42/48 | €463k |
| Trade debts payable within one year | 44 | €351k |
| Income statement | ||
| Turnover | 70 | €384k |
| Operating result | 9901 | €-2.48M |
| Financial income | 75 | €229k |
| Financial charges | 65 | €118k |
| Result before taxes | 9903 | €-2.37M |
| Net result for the period | 9904 | €-2.37M |
| Result to be appropriated | 9905 | €-2.37M |
Directors & mandates
Current directors & mandates
-
Current02-08-2024 → present
-
Current02-08-2024 → present
2 events
- 02-08-2024 Appointed· Manager
- 02-08-2024 Appointed· Managing director
Statutory auditor
| Finvision BedrijfsrevisorenCurrent Statutory auditor · represented by Thomas Durieux | 03-12-2025 → present |
Legal Structure
| NACE primary | Research and development on biotechnology(72101) |
| Legal form | Public limited company(014) |
| Incorporation | 29-07-2024 |
| Status | Active |
| Postal code | 2620 |
Establishment units
axabio
since 20242.362.052.245
Real-estate footprint
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11018B0152/00B003 | Flanders | 3,122 m² | 1 · 369 m² | 6.6 m · 2 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
19-06
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Liquidity triplescurrent ratio 2.21
Current ratio from 0.78 to 2.21.
03-12
State Gazette act
Director changes
v3.2
10-10
State Gazette act
Statutes amendment
v3.2
05-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
14-03
State Gazette act
Director changes
v3.2
2024
08-08
State Gazette act
Incorporation
oprichting
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 4 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Belgisch Staatsblad, acts
All acts · 4
updated 9 months ago
2025
03-12-2025 1 director appointed, 1 resigning
- Thomas Durieux, Commissaris
- BDO Bedrijfsrevisoren, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BDO Bedrijfsrevisoren",
"address": null,
"birth_date": null
},
"effective_date": "2024-06-28",
"evidence_quote": "De aandeelhouders beslissen met eenparigheid van stemmen om het mandaat als commissaris van de besloten vennootschap BDO Bedrijfsrevisoren met zetel te 1930 Zaventem, Da Vincilaan 9, Bus E.6 ingeschreven in het rechtspersonenregister onder nummer BTW BE 0431.088.289, RPR Brussel, met als permanente "
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Thomas Durieux",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Finvision Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De aandeelhouders beslissen met eenparigheid van stemmen om de besloten vennootschap Finvision Bedrijfsrevisoren (IBR B00829), kantoorhoudende te Vredestraat 55 in 8790 Waregem en vertegenwoordigd door de heer Thomas Durieux, bedrijfsrevisor (IBR A02082), te benoemen tot commissaris voor de boekjare"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1011.997.238",
"name_full": "AXABIO",
"legal_form": "NV"
}
}10-10-2025 Articles of association amended
Summary:
v3.2
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": true,
"effective_date": "2025-09-30",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "1011.997.238",
"name_full": "AXABIO",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "Wordt (worden) gemachtigd, elk met de bevoegdheid om alleen te handelen en met recht van indeplaatsstelling, om de inschrijving van de vennootschap in de Kruispuntbank van Ondernemingen alsook haar registratie bij de btw-administratie aan te passen en/of te schrappen in functie van de besluiten vastgesteld in deze akte, evenals voor het vervullen van de formaliteiten inzake eStox, en ... om in dit verband alle verklaringen af te leggen en alle documenten in te vullen en te ondertekenen in naam en voor rekening van de vennootschap, haar aandeelhouders, bestuurders en/of vereffenaars ... : de heer Filip BEYERS, wonende te 2150 Antwerpen (Borsbeek), Hulgenrodestraat 35.",
"holder_kbo": null,
"holder_name": "Filip BEYERS",
"scope_categories": [
"KBO",
"tax",
"filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}14-03-2025 3 directors appointed
- Wim Michiels, Zaakvoerder
- Wim Michiels, Gedelegeerd bestuurder
- Mark Michiels, Gedelegeerd bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Wim Michiels",
"address": null,
"birth_date": null
},
"effective_date": "2024-08-02",
"evidence_quote": "De raad van bestuur benoemt Wim Michiels, Van Peltstraat 23 2018 Antwerpen, als voorzitter van de vennootschap met ingang van heden."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Wim Michiels",
"address": null,
"birth_date": null
},
"effective_date": "2024-08-02",
"evidence_quote": "De raad van bestuur benoemt Wim Michiels, Van Peltstraat 23 2018 Antwerpen, als gedelegeerd bestuurder van de vennootschap met ingang van heden."
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Mark Michiels",
"address": null,
"birth_date": null
},
"effective_date": "2024-08-02",
"evidence_quote": "De raad van bestuur benoemt Mark Michiels, Oudekerkstraat 26 2018 Antwerpen, als gedelegeerd bestuurder van de vennootschap met ingang van heden."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "1011.997.238",
"name_full": "AXABIO",
"legal_form": "NV"
}
}2024
08-08-2024 Incorporation of a new NV
Summary:
oprichting
Technical details
{
"kind": "oprichting",
"seat": "Nieuwe Dreef 2 te 2620 Hemiksem",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": null,
"name": "PROVIRON HOLDING"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "Aandelen van dezelfde aard als de aandelen van de partieel te splitsen vennootschap",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "PROVIRON HOLDING",
"contribution_type": "in_kind",
"amount_paid_in_eur": 0,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 1975000,
"amount_subscribed_eur": 3114393.44,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 3114393.44,
"subject_company": {
"kbo": "1011.997.238",
"name_full": "axabio",
"legal_form": "NV"
},
"initial_directors": [],
"incorporation_date": "2024-01-01",
"post_incorporation_mandates": []
}Credit advice
Company registry (CBE)
Activities
Manufacture of chemicals and chemical products20140Research and development on biotechnology72101
Names & trade names
| Legal nameNL | axabio |
Similar companies
Dokter Dirk HENDRICK
BE 0878.194.844 · Gent
EQUALY
BE 0667.996.636 · Ottignies-Louvain-la-Neuve
SYNLOCK
BE 0792.288.674 · Jemeppe-sur-Sambre
care2trans
BE 0669.887.344 · Merelbeke-Melle
COOPSTROOM
BE 0675.918.368 · Brugge